NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/09/2022
Back to search
Official data from USPTO
LYPRINEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
09/09/2022
Trademark type
Word
Nice classes
5
Filing date
08/31/2011
Registration date
10/30/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/09/2022
Last transaction
09/09/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
1994-00-00
First use in commerce
1994-00-00
Drawing code
4
Owner type
16
Owner location
Central Hong Kong, HK
Examiner
HALMEN, KATY
Law office
L90
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Pharmalink International Limited
Representatives
Elizabeth A. Cominolli Markert & Cominolli PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and products for the treatment of inflammatory conditionsincluding the treatment of arthritis and arthritic pain; natural medicine in the nature of natural pharmaceutical preparations for the treatment of inflammatory conditionsincluding the treatment of arthritis and arthritic pain; natural medicines in the nature of natural pharmaceutical preparations containing extracts from shellfish for the treatment of inflammatory conditionsincluding the treatment of arthritis and arthritic pain; dietary supplements derived from seafood and shellfish adapted for medical use as an anti-inflammatorynone of the aforesaid goods for veterinary use or for use in animal health
Publications
History of USPTO decisions and trademark events.
34 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/09/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/09/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/09/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
03/17/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/30/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/07/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/07/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/07/2018
E815
TEAS SECTION 8 & 15 RECEIVED
10/22/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/30/2017
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
02/13/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/12/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
10/30/2012
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
09/24/2012
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/29/2012
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
08/09/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/10/2012
PUBO
PUBLISHED FOR OPPOSITION
07/10/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/20/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/01/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/25/2012
ACEC
AMENDMENT FROM APPLICANT ENTERED
05/24/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/24/2012
PAPER RECEIVED
05/07/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/19/2011
GNRT
NON-FINAL ACTION E-MAILED
12/19/2011
CNRT
NON-FINAL ACTION WRITTEN
12/19/2011
DOCK
ASSIGNED TO EXAMINER
12/19/2011
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/26/2011
ALIE
ASSIGNED TO LIE
10/24/2011
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/12/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/06/2011
NWAP
NEW APPLICATION ENTERED
09/03/2011
Continuous trademark protection
Get notified about every new filing that threatens LYPRINEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.